The use cases of the blockchain technology are not limited. As the technology rose to new heights of popularity during the bull run of 2021, it was made clear that the complete potential of blockchain has yet to be explored. While it originated as general blockchains, the technology has advanced to the level that now […]
MediBloc – Blockchains in the healthcare system Read More »
Li-Cycle Holdings Corp. (LICY) stock soared 8.64% in the current-market trading session at the price of $11.95 following the announcement of a $100 million investment from Koch Strategic Platforms (KSP). Li-Cycle delivers a customer-centric solution for lithium-ion batteries by leveraging its innovative Spoke & Hub Technologies. Lithium-ion batteries are automotive and have consumer electronics and
Li-Cycle Holdings Corp. (LICY) Stock Surged 8.64% Today, Here’s Why Read More »
Jiuzi Holdings, Inc. (JZXN) stock soared 12.65% in the current-market trading session at the price of $2.76 after it entered into a strategic cooperation agreement with Shaanxi Tongjia Auto. Jiuzi Holdings is a Chinese company with thirty-one operating franchise stores and one company-owned store. It sells battery-operated electric vehicles and sources New Energy Vehicles (NEVs)
Jiuzi Holdings, Inc. (JZXN) Stock Surged 12.65% Today, Here’s Why Read More »
EQT Corporation (EQT) stock plummeted 4.91% in the current market trading session at the price of $21.00 following the announcement of pricing of an underwritten public offering of common stock. EQT is a natural gas production company that provides world-class asset base and is the operator of choice for the stakeholders. Pricing of Offering of
EQT Corporation (EQT) Stock Plunged 4.91% Today, Here’s Why Read More »
Fortress Biotech, Inc. (FBIO), a biopharmaceutical company, has seen a surge of 13.53% in the premarket trading session. Consequently, FBIO stock is changing hands at $3.86 at the time of this writing. The surge has come after the company announced today the receipt of the Notice of option exercise from Astra Zeneca. The surge has
Fortress Biotech, Inc. (FBIO) Stock Surging in Premarket Read More »
LifeMD, Inc. (LFMD), a direct-to-patient telehealth company, has seen a decline of 12.70% in the premarket trading session. Consequently, LFMD stock is changing hands at $5.98 at the time of writing. The decline has come after the company announced the launch of a public offering of common stock in the late hours of Tuesday. LFMD
LifeMD, Inc. (LFMD) Stock Plummeting in Premarket, Here’s Why Read More »
Digital Brands Group, Inc. (DBGI), a company retailing apparel, has seen a decline of 4.26% in the premarket trading session. As a result, DBGI stock is changing hands at $3.37 at the time of writing. The decline has come after the stock gained a 19.32% increase in Tuesday’s regular trading hours. The increase came due
Digital Brands Group, Inc. (DBGI) Stock Steadily declining After Tremendous Tuesday Read More »
Applied Genetic Technologies Inc. (NASDAQ: AGTC) stock plunged by 3.7% at last close whereas the AGTC stock price gains by 2.56% in the pre-market trading session. AGTC is a clinical-stage biotechnology firm focused on discovering genetic treatments for patients suffering from uncommon and debilitating ophthalmic, otologic, and CNS disorders. AGTC stock’ Important Event The Fourteenth
Iterum Therapeutics plc (ITRM), a clinical-stage pharmaceutical company, has seen an increase of 21.65% in the premarket trading session. As a result, ITRM stock was trading at $0.67 when last checked. The reason for this gain appears to be the update by the company regarding a meeting with FDA about Oral Sulopenem. On Tuesday, ITRM stock
Iterum Therapeutics plc (ITRM) Stock Showing a Bullish Trend, Here’s Why Read More »
Hepion Pharmaceuticals Inc. (NASDAQ: HEPA) stock declined by 1.9% at last close whereas the HEPA stock-price gains by 5.81% in the pre-market trading session. Hepion Pharmaceuticals is a clinical-stage pharmaceutical business focused on AI-driven therapeutic medication discovery for non-alcoholic steatohepatitis and liver disorders. HEPA stock’ Recent Past Development Hepion Pharmaceuticals has released new effectiveness results
At Stocktstelegraph.com, we are committed to helping investors make smart and profitable decisions. Our goal is to make investing easier and more accessible to everyone. We strive to provide the best and most reliable market information, news and analysis to ensure that our readers can make informed decisions.